accountStock quotes in this article:PFE, KG NEW YORK (TheStreet) -- Pfizer(PFE) is buying King Pharmaceuticals(KG) for $3.6 billion in cash to bolster its presence in the pain relief market, the company said Tuesday. More from Adam Feuerstein Market Activity...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Buying King Pharma
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account